• CX-4945 (Silmitasertib): CK2 Research Guide

  2026-09-01

  CX-4945, also called Silmitasertib, is a selective ATP-competitive CK2 inhibitor used to study PI3K/Akt signaling, apoptosis, and context-dependent cell-cycle control. Product data and a 2026 ischemic-stroke study support CX-4945 as a mechanistic CK2 probe, but they do not establish a universal anticancer or clinical treatment effect.

• Ac-YVAD-CMK for Membrane-Inflammation Dissection

  2026-09-01

  Ac-YVAD-CMK enables mechanistic separation of caspase-1-driven inflammation from plasma-membrane repair in Kupffer cell and Listeria models. This article translates TMEM16F research into a decision framework for interpreting cytokines, pyroptosis, and liver injury data.

• AZD2461: A Novel PARP Inhibitor Workflow

  2026-08-31

  AZD2461 is a novel PARP inhibitor for connecting PARP-1 suppression with DNA damage response, cell-cycle arrest, and cancer-cell killing. A paired viability-and-death workflow helps distinguish true cytotoxicity from reversible growth inhibition while testing resistance biology in breast cancer models.

• DON Liver Injury: Mitophagy and Nrf2 Signaling

  2026-08-31

  This study proposes that deoxynivalenol-induced liver injury is driven by excessive PINK1/Parkin-mediated mitophagy together with suppression of the p62–Keap1–Nrf2 cytoprotective pathway. Mouse and AML-12 cell experiments, including pathway inhibition and p62 rescue, provide a mechanistic framework for interpreting mitochondrial damage, oxidative stress, inflammation, apoptosis, and lipid metabolic disruption.

• AZD2461: A Better Way to Read PARP Responses

  2026-08-30

  AZD2461 is a novel PARP inhibitor for dissecting DNA repair pathway modulation, drug resistance, and response kinetics in breast cancer models. This guide pairs its mechanistic profile with a rigorous framework for separating growth inhibition from true cell killing in vitro.

• VX-661: F508del CFTR Corrector Workflow

  2026-08-29

  Build more interpretable cystic fibrosis research assays with VX-661 by separating CFTR trafficking rescue from channel potentiation. This workflow combines practical dosing, orthogonal surface-expression and function readouts, and calnexin-aware controls for variant-specific optimization.

• Vincristine sulfate: Reliable Cell Assay Workflows

  2026-08-28

  Learn how Vincristine sulfate (SKU A1765) supports reproducible viability, proliferation, and cytotoxicity experiments through a defined microtubule-disruption mechanism and practical solubility guidance. This scenario-based guide covers assay design, dose selection, data interpretation, and product evaluation for cancer research.

• Phage-Layer Interferometry for Phage Diagnostics

  2026-08-28

  The reference study introduces phage-layer interferometry (PLI) as a quantitative companion diagnostic for selecting therapeutic phages and as a prototype platform for bacterial detection. Its key practical advance is real-time, automatable analysis that remains usable in complex opaque matrices, where conventional optical assays are difficult to interpret.

• CCT007093: PPM1D Inhibitor Workflow

  2026-08-27

  CCT007093 is a practical chemical probe for connecting PPM1D inhibition with p38 signaling, viability loss, and inflammatory cell-death phenotypes. This workflow shows how to move from solvent and dose controls to mechanistic rescue experiments in breast cancer and renal tubular models.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide

  2026-08-27

  This reagent provides HRP-mediated detection of rabbit primary IgG in Western blot, ELISA, IHC, and IC workflows. It should be used as a research secondary antibody with assay-specific optimization, not as a diagnostic reagent or as evidence of performance beyond the supplied product dossier.

• Bradykinin: Practical Assay Handling Guide

  2026-08-26

  Bradykinin (SKU BA5201) provides a defined peptide perturbation for vascular reactivity, permeability, smooth muscle, pain, and inflammation experiments. This guide covers storage, solution handling, controls, and troubleshooting; the material is for scientific research only and should not be used for diagnosis, treatment, or direct medical application.

• Catalpol, Glycolysis, and EphA2 in Liver Fibrosis

  2026-08-26

  The reference study identifies a mechanistic link between catalpol, aerobic glycolysis, and EphA2/FAK/Src signaling in hepatic stellate cells. Using complementary mouse and cell models, it shows that catalpol reduces stellate-cell activation, inflammation, and fibrotic remodeling, while highlighting EphA2 as a potential metabolic control point.

• Biotin-XX Tyramide Reagent in Spatial Proteomics

  2026-08-25

  Biotin-XX Tyramide Reagent combines HRP-driven amplification with membrane exclusion for selective cell-surface detection in tissue sections. This guide translates its chemistry into practical IHC, ISH, multiplex imaging, and proximity-proteomics workflows, with starting parameters and troubleshooting advice.

• Nystatin (Fungicidin): Mechanism & Benchmarks

  2026-08-25

  Nystatin, also called Fungicidin, is an ergosterol-binding polyene antifungal used in Candida and Aspergillus research. Product-dossier benchmarks include species-dependent Candida inhibition, reduced epithelial adhesion, and protective activity from liposomal Nystatin in neutropenic mice.

• Neuromedin S (rat): Protocol and QC Guide

  2026-08-24

  Neuromedin S (rat) provides a defined endogenous peptide agonist for controlled studies of neuromedin U receptor signaling and GPCR/G protein signaling in rat-relevant systems. It supports research workflows involving energy homeostasis regulation and stress response research, but the dossier does not establish potency, therapeutic suitability, diagnostic use, or cross-species performance.

7797 records 1/520 page Next 12345 下5页 Last page